Amrutanjan Health Care has inked a memorandum of understanding (MoU) with US-based Austin Chemical.
Subscribe to our email newsletter
Under the pact, both the companies have decided to establish a joint venture, Amrutanjan Pharmaessense Ltd (Pharmaessense).
Amrutanjan’s fine chemical division Pharmaessense provides value added servics to several multinational corporation as a CRAMS (Contract Research and Manufacturing Services) company.
Amrutanjan’s facility, based in Alathur, Chennai, will focus on the supply of non-GMP and cGMP intermediates and APIs from gram scale to commercial quantities.
Pharmaessense currently has lab facilities to house 55 scientists and a new world-class kilo lab / pilot plant facility that conforms to ICH Q7 guidelines (Class 100,000), in addition to a fully-equipped GLP analytical lab.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.